Cardiology Department, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre and Cardiovascular Centre, University of Lisbon, Lisboa, Portugal; Faculty of Medicine, University of Lisbon, Lisboa, Portugal.
Cardiology Department, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre and Cardiovascular Centre, University of Lisbon, Lisboa, Portugal; Faculty of Medicine, University of Lisbon, Lisboa, Portugal.
Rev Port Cardiol (Engl Ed). 2021 Oct;40(10):741-752. doi: 10.1016/j.repce.2021.08.002. Epub 2021 Nov 19.
Pulmonary endarterectomy (PEA) is a potentially curative procedure in patients with chronic thromboembolic pulmonary hypertension (CTEPH). This study reports the initial experience of a Portuguese PH center with patients undergoing PEA at an international surgical reference center.
Prospective observational study of consecutive CTEPH patients followed at a national PH center, who underwent PEA at an international surgical reference center between October 2015 and March 2019. Clinical, functional, laboratory, imaging and hemodynamic parameters were obtained in the 12 months preceding the surgery and repeated between four and six months after PEA.
27 consecutive patients (59% female) with a median age of 60 (49-71) years underwent PEA. During a median follow-up of 34 (21-48) months, there was an improvement in functional class in all patients, with only one cardiac death. From a hemodynamic perspective, there was a reduction in mean pulmonary artery pressure from 48 (42-59) mmHg to 26 (22-38) mmHg, an increase in cardiac output from 3.3 (2.9-4.0) L/min to 4.9 (4.2-5.5) L/min and a reduction in pulmonary vascular resistance from 12.1 (7.2-15.5) uW to 3.5 (2.6-5,2) uW. During the follow-up, 44% (n=12) of patients had no PH criteria, 44% (n=12) had residual PH and 11% (n=3) had PH recurrence. There was a reduction of N-terminal pro-B-type natriureticpeptide from 868 (212-1730) pg/mL to 171 (98-382) pg/mL. Rright ventricular systolic function parameters revealed an improvement in longitudinal systolic excursion and peak velocity of the plane of the tricuspid ring from 14 (13-14) mm and 9 (8-10) cm/s to 17 (16-18) mm and 13 (11-15) cm/s, respectively. Of the 26 patients with preoperative right ventricular dysfunction, 85% (n=22) recovered. The proportion of patients on specific vasodilator therapy decreased from 93% to 44% (p<0.001) and the proportion of those requiring oxygen therapy decreased from 52% to 26% (p=0.003). The six-minute walk test distance increased by about 25% compared to the baseline and only eight patients had significant desaturation during the test.
Pulmonary endarterectomy performed at an experienced high-volume center is a safe procedure with a very favorable medium-term impact on functional, hemodynamic and right ventricular function parameters in CTEPH patients with operable disease. It is possible for PH centers without PEA differentiation to refer patients safely and effectively to an international surgical center in which air transport is necessary.
肺动脉内膜剥脱术(PEA)是治疗慢性血栓栓塞性肺动脉高压(CTEPH)患者的一种潜在根治性手术。本研究报告了葡萄牙一家肺动脉高压中心在国际外科参考中心对接受 PEA 的 CTEPH 患者的初步经验。
对在国家肺动脉高压中心接受治疗并在 2015 年 10 月至 2019 年 3 月期间在国际外科参考中心接受 PEA 的连续 CTEPH 患者进行前瞻性观察性研究。在手术前的 12 个月内获得临床、功能、实验室、影像学和血流动力学参数,并在 PEA 后 4 至 6 个月之间重复。
27 例连续患者(59%为女性),中位年龄为 60(49-71)岁,接受了 PEA。在中位随访 34(21-48)个月期间,所有患者的功能分级均有所改善,仅 1 例出现心脏死亡。从血流动力学角度来看,平均肺动脉压从 48(42-59)mmHg 降至 26(22-38)mmHg,心输出量从 3.3(2.9-4.0)L/min 增加至 4.9(4.2-5.5)L/min,肺血管阻力从 12.1(7.2-15.5)uW 降至 3.5(2.6-5.2)uW。在随访期间,44%(n=12)的患者无 PH 标准,44%(n=12)有残留 PH,11%(n=3)有 PH 复发。N 端脑利钠肽前体从 868(212-1730)pg/ml 降至 171(98-382)pg/ml。右心室收缩功能参数显示纵向收缩位移和三尖瓣环平面收缩速度分别从 14(13-14)mm 和 9(8-10)cm/s 改善至 17(16-18)mm 和 13(11-15)cm/s。26 例术前右心室功能障碍患者中,85%(n=22)恢复。需要特定血管扩张剂治疗的患者比例从 93%降至 44%(p<0.001),需要氧疗的患者比例从 52%降至 26%(p=0.003)。六分钟步行试验距离比基线增加了约 25%,只有 8 名患者在试验中出现明显的低氧血症。
在有经验的高容量中心进行肺动脉内膜剥脱术是一种安全的手术,对可手术治疗的 CTEPH 患者的功能、血流动力学和右心室功能参数具有非常有利的中期影响。没有 PEA 分化的肺动脉高压中心可以安全有效地将患者转介到需要空运的国际外科中心。